Lynn Dorsey Bleil's most recent trade in Amicus Therapeutics Inc was a trade of 74,872 Stock Options (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Therapeutics Inc | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 74,872 | 74,872 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 20,414 | 113,941 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 42,467 | 42,467 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 11,847 | 93,527 (0%) | 0% | 0 | Common Stock | |
| Stericycle Inc. | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 3,524 | 22,191 | - | - | Restricted Stock Units | |
| Amicus Therapeutics Inc | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 30,474 | 30,474 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 8,584 | 81,680 (0%) | 0% | 0 | Common Stock | |
| Stericycle Inc. | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 3,620 | 18,497 | - | - | Restricted Stock Units | |
| Amicus Therapeutics Inc | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 45,423 | 45,423 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 12,671 | 73,096 (0%) | 0% | 0 | Common Stock | |
| Stericycle Inc. | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 2,928 | 14,877 | - | - | Restricted Stock Units | |
| Amicus Therapeutics Inc | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 36,111 | 36,111 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,115 | 60,425 (0%) | 0% | 0 | Common Stock | |
| Stericycle Inc. | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 1,837 | 11,949 | - | - | Restricted Stock Units | |
| Amicus Therapeutics Inc | Lynn Dorsey Bleil | Director | Purchase of securities on an exchange or from another person at price $ 8.74 per share. | 25 May 2021 | 28,605 | 50,310 (0%) | 0% | 8.7 | 250,008 | Common Stock |
| Stericycle Inc. | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 303 | 10,112 | - | - | Restricted Stock Units | |
| Stericycle Inc. | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 353 | 9,809 | - | - | Restricted Stock Units | |
| Stericycle Inc. | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2020 | 371 | 9,456 | - | - | Restricted Stock Units | |
| Stericycle Inc. | Lynn Dorsey Bleil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2020 | 382 | 9,085 | - | - | Restricted Stock Units |